-
Signature
-
/s/ Paul Rimas, as Attorney-in-Fact
-
Stock symbol
-
TRMB
-
Transactions as of
-
Apr 15, 2024
-
Transactions value $
-
$161,319
-
Form type
-
4
-
Date filed
-
4/17/2024, 02:01 PM
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
TRMB |
Common Stock |
Options Exercise |
$114K |
+1.89K |
+19.05% |
$60.54 |
11.8K |
Apr 15, 2024 |
Direct |
|
| transaction |
TRMB |
Common Stock |
Tax liability |
-$42.1K |
-695 |
-5.88% |
$60.54 |
11.1K |
Apr 15, 2024 |
Direct |
|
| transaction |
TRMB |
Common Stock |
Options Exercise |
$163K |
+2.7K |
+24.28% |
$60.54 |
13.8K |
Apr 15, 2024 |
Direct |
|
| transaction |
TRMB |
Common Stock |
Tax liability |
-$60.1K |
-992 |
-7.18% |
$60.54 |
12.8K |
Apr 15, 2024 |
Direct |
|
| transaction |
TRMB |
Common Stock |
Sale |
-$14.4K |
-235 |
-1.83% |
$61.14 |
12.6K |
Apr 15, 2024 |
Direct |
F1 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
TRMB |
Restricted Stock Unit |
Options Exercise |
$0 |
-1.89K |
-50% |
$0.00 |
1.89K |
Apr 15, 2024 |
Common Stock |
1.89K |
$0.00 |
Direct |
F2 |
| transaction |
TRMB |
Restricted Stock Unit |
Options Exercise |
$0 |
-2.7K |
-33.33% |
$0.00 |
5.4K |
Apr 15, 2024 |
Common Stock |
2.7K |
$0.00 |
Direct |
F3 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: